Browsing Tag

Ind CEPI

First mRNA-Based COVID 19 Vaccine Gets Nod for Phase II/III Trial

Team DP Aug 25, 2021 0

The fight against the ongoing epidemic of COVID-19 is all set to get stronger. The office of the Drug Controller General of India has approved a proposal of the Pune-based Gennova Biopharmaceuticals Ltd., to go in for phase II / III trial…
Read More...

Our Campaigns

Support & Donate Now

The role of journalism is strongly challenged now more than ever before. It is imperative that the fourth pillar of democracy publish news and views in its most credible form. We at Delhi Post place the highest regard for freedom of expression. We strive to publish the truth and assert credibility over chaos. To safeguard the independent, non-partisan space, we depend on the support of our readers and contributors. Please Donate Now and join us in maintaining this platform which is a voice for every individual with an opinion!